ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Repligen Corp

Repligen Corp (RGEN)

155,70
-4,41
(-2,75%)
Geschlossen 09 März 9:00PM
155,70
-0,12
(-0,08%)
Nach Börsenschluss: 12:01AM
Fortg. Diagramm

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
155,70
Gebot
142,00
Fragen
165,31
Volumen
923.871
149,88 Tagesbereich 161,68
113,50 52-Wochen-Bereich 203,13
Marktkapitalisierung
Handelsende
160,11
Handelsbeginn
159,63
Letzte Trade
2
@
154
Letzter Handelszeitpunkt
Finanzvolumen
US$ 143.156.786
VWAP
154,9532
Durchschnittliches Volumen (3 Mio.)
590.936
Ausgegebene Aktien
56.026.725
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
245,27
Gewinn pro Aktie (EPS)
0,64
Erlöse
662,93M
Nettogewinn
35,6M

Über Repligen Corp

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceuti... Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Repligen Corp is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RGEN. The last closing price for Repligen was US$160,11. Over the last year, Repligen shares have traded in a share price range of US$ 113,50 to US$ 203,13.

Repligen currently has 56.026.725 shares in issue. The market capitalisation of Repligen is US$8,97 billion. Repligen has a price to earnings ratio (PE ratio) of 245.27.

RGEN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.190.12217863803155.51163.78147.37574697157.34296488CS
4-5.63-3.48974152359161.33169143.03676354156.18231687CS
12-0.84-0.536604062859156.54181.66140.62590936157.21169397CS
268.765.96161698653146.94181.66121.52603529148.33431412CS
52-40.6-20.6826286296196.3203.13113.5648648149.67251249CS
156-23.55-13.1380753138179.25262.26110.45599524164.93443042CS
26067.0675.6543321388.64327.3278.41537237170.84526104CS

RGEN - Frequently Asked Questions (FAQ)

What is the current Repligen share price?
The current share price of Repligen is US$ 155,70
How many Repligen shares are in issue?
Repligen has 56.026.725 shares in issue
What is the market cap of Repligen?
The market capitalisation of Repligen is USD 8,97B
What is the 1 year trading range for Repligen share price?
Repligen has traded in the range of US$ 113,50 to US$ 203,13 during the past year
What is the PE ratio of Repligen?
The price to earnings ratio of Repligen is 245,27
What is the cash to sales ratio of Repligen?
The cash to sales ratio of Repligen is 13,17
What is the reporting currency for Repligen?
Repligen reports financial results in USD
What is the latest annual turnover for Repligen?
The latest annual turnover of Repligen is USD 662,93M
What is the latest annual profit for Repligen?
The latest annual profit of Repligen is USD 35,6M
What is the registered address of Repligen?
The registered address for Repligen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Repligen website address?
The website address for Repligen is www.repligen.com
Which industry sector does Repligen operate in?
Repligen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,14M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,92M
KZIAKazia Therapeutics Ltd
US$ 1,1899
(40,80%)
4,5M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M

RGEN Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht